Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy
- Bernardo, Bianca C
- Gao, Xiao-Ming
- Tham, Yow Keat
- Kiriazis, Helen
- Winbanks, Catherine E
- Ooi, Jenny Ying Ying
- Boey, Esther J H
- Obad, Susanna
- Kauppinen, Sakari
- Gregorevic, Paul
- Du, Xiao-Jun
- Lin, Ruby C Y
- McMullen, Julie Rae
Publication date
January 2014
DOIAbstract
The aim of this study was to assess whether inhibition of miR-34a could attenuate cardiac remodeling in a mouse model with pre-existing pathological hypertrophy
Add to ORKG